Readership Survey 2007 - Third party
Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.
Industry updates and clinical trial data at the upcoming 2025 ARVO Annual Meeting
Therapies for retinal vascular disease, dry eye disease, inflammation following glaucoma filtration surgery and more
PHOTON Results and Their Relation to DME Patients in Your Practice
John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.
Artificial intelligence analyses biomarker changes in neovascular AMD treated with faricimab
The phase 3 LUCERNE and TENAYA trials suggested that faricimab may allow clinicians to extend the interval between injections to up to 16 weeks after an initial loading phase
PULSAR Results and Their Relation to nAMD Patients in Your Practice
John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.
Journal of Neuroinflammation publishes data on Eleva’s lead retinal asset CPV-104
In an established animal model of age-related macular degeneration, Eleva’s recombinant human CPV-104 improved two hallmarks of the disease
Alcon marks 110th anniversary of Grieshaber AG site in Switzerland
Alcon acquired the historic ophthalmic instrument company in 2000